What is GSK stock price today?

Visit our real-time dashboard for the current GSK stock price and live market data.

Is GSK stock going up or down today?

GSK stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GSK stock now?

The decision to buy GSK depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GSK a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GSK based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GSK stock overvalued or undervalued?

GSK currently trades at a P/E ratio of 13.49, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if GSK is fairly priced.

What is GSK's P/E ratio?

GSK has a price-to-earnings (P/E) ratio of 13.49, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is GSK's market cap?

GSK (GlaxoSmithKline PLC ADR) has a market capitalization of $103.31 billion, making it a mid-cap stock.

What is GSK's price to book ratio?

Price-to-book ratio for GSK is available on our dashboard along with other valuation metrics.

Does GSK pay dividends?

Yes, GSK pays dividends with a current yield of 3.50%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is GSK's dividend yield?

GSK's dividend yield is 3.50%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is GSK stock a good long-term investment?

GSK's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GSK's revenue growth rate?

Revenue growth data for GSK is available on our dashboard with detailed financial statement analysis.

Profitability metrics for GSK are available on our dashboard with complete income statement analysis.

What are the risks of investing in GSK?

Key risks for GSK include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GSK compare to its competitors?

Compare GSK to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GSK's performance and positioning.

What is GSK's stock price target for 2026?

Visit our prediction page for AI-powered price targets for GSK with bull, base, and bear case scenarios.

What do analysts say about GSK?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GSK. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GSK's next earnings report?

GSK reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GSK - GlaxoSmithKline PLC ADR

NYSE * Healthcare * Drug Manufacturers - General

$0.00

+$0.00 (+0.00%)

About GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR (GSK) common stock

Price Chart

Loading chart...

GSK Key Statistics

Market Cap

$103.31B

P/E Ratio

13.49

Dividend Yield

3.50%

How GSK Compares to Peers

GSK has the lowest P/E ratio in Drug Manufacturers - General, suggesting it may be the most undervalued

GSK is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
GSK(This stock)	$103.31B	13.5	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 22, 2026 at 6:21 AM EDT

Ready to invest in GSK?

Commission-free trading available. Affiliate links.

Upcoming Events for GSK

Dashboard

Enter a ticker to analyze